|
1
|
Collins AT, Berry PA, Hyde C, et al:
Prospective identification of tumorigenic prostate cancer stem
cells. Cancer Res. 65:10946–10951. 2005.
|
|
2
|
Liu S, Dontu G, Mantle ID, et al: Hedgehog
signaling and Bmi-1 regulate self-renewal of normal and malignant
human mammary stem cells. Cancer Res. 66:6063–6071. 2006.
|
|
3
|
van der Flier LG and Clevers H: Stem
cells, self-renewal, and differentiation in the intestinal
epithelium. Annu Rev Physiol. 71:241–260. 2009.
|
|
4
|
Chen T, Yang K, Yu J, et al:
Identification and expansion of cancer stem cells in tumor tissues
and peripheral blood derived from gastric adenocarcinoma patients.
Cell Res. 22:248–258. 2012.
|
|
5
|
Ryu HS, Park do J, Kim HH, et al:
Combination of epithelial-mesenchymal transition and cancer stem
cell-like phenotypes has independent prognostic value in gastric
cancer. Hum Pathol. 43:520–528. 2012.
|
|
6
|
Matoba R, Niwa H, Masui S, et al:
Dissecting Oct3/4-regulated gene networks in embryonic stem cells
by expression profiling. PLoS One. 1:e262006.
|
|
7
|
Takeda J, Seino S and Bell GI: Human Oct3
gene family: cDNA sequences, alternative splicing, gene
organization, chromosomal location, and expression at low levels in
adult tissues. Nucleic Acids Res. 20:4613–4620. 1992.
|
|
8
|
Matsuoka J, Yashiro M, Sakurai K, et al:
Role of the stemness factors sox2, oct3/4, and nanog in gastric
carcinoma. J Surg Res. 174:130–135. 2012.
|
|
9
|
Santiago JM, Sasako M and Osorio J:
TNM-7th edition 2009 (UICC/AJCC) and Japanese Classification 2010
in Gastric Cancer. Towards simplicity and standardisation in the
management of gastric cancer. Cir Esp. 89:275–281. 2011.(In
Spanish).
|
|
10
|
Song Z and Cheng L: Gastric stem cells and
gastric cancer stem cells. Zhong Hua Yi Xue Za Zhi. 89:1868–1870.
2009.(In Chinese).
|
|
11
|
Schreiber E, Tobler A, Malipiero U, et al:
cDNA cloning of human N-Oct3, a nervous-system specific POU domain
transcription factor binding to the octamer DNA motif. Nucleic
Acids Res. 21:253–258. 1993.
|
|
12
|
Looijenga LH, Stoop H, de Leeuw HP, et al:
POU5F1 (OCT3/4) identifies cells with pluripotent potential in
human germ cell tumors. Cancer Res. 63:2244–2250. 2003.
|
|
13
|
Kekuda R, Prasad PD, Wu X, et al: Cloning
and functional characterization of a potential-sensitive,
polyspecific organic cation transporter (OCT3) most abundantly
expressed in placenta. J Biol Chem. 273:15971–15979. 1998.
|
|
14
|
De Jong J, Stoop H, Dohle GR, et al:
Diagnostic value of OCT3/4 for pre-invasive and invasive testicular
germ cell tumours. J Pathol. 206:242–249. 2005.
|
|
15
|
Rao P, Tannir NM and Tamboli P: Expression
of OCT3/4 in renal medullary carcinoma represents a potential
diagnostic pitfall. Am J Surg Pathol. 36:583–588. 2012.
|
|
16
|
Wang Q, He W, Lu C, et al: Oct3/4 and Sox2
are significantly associated with an unfavorable clinical outcome
in human esophageal squamous cell carcinoma. Anticancer Res.
29:1233–1241. 2009.
|
|
17
|
Wang P, Branch DR, Bali M, et al: The POU
homeodomain protein OCT3 as a potential transcriptional activator
for fibroblast growth factor-4 (FGF-4) in human breast cancer
cells. Biochem J. 375:199–205. 2003.
|
|
18
|
Chen Z, Xu WR, Qian H, et al: Oct4, a
novel marker for human gastric cancer. J Surg Oncol. 99:414–419.
2009.
|
|
19
|
Kikuchi S, Katada N, Sakuramoto S, et al:
Factors associated with pN3 stage tumors according to the TNM
classification in advanced gastric cancer. Hepatogastroenterology.
50:1723–1726. 2003.
|
|
20
|
Omejc M, Juvan R, Jelenc F and Repse S:
Lymph node metastases in gastric cancer: correlation between new
and old UICC TNM classification. Int Surg. 86:14–19. 2001.
|
|
21
|
Asadi MH, Mowla SJ, Fathi F, et al:
OCT4B1, a novel spliced variant of OCT4, is highly expressed in
gastric cancer and acts as an antiapoptotic factor. Int J Cancer.
128:2645–2652. 2011.
|
